Drug Pricing

NASHP Issues RFP for Partner to Help States Develop a Drug Cost Transparency Database

NASHP’s Center for State Rx Drug Pricing seeks a partner to provide technical and strategic expertise to help a workgroup of state officials from California, Nevada, Oregon, Connecticut, and Vermont implement their drug cost transparency laws and help Maine and New Hampshire develop transparency programs as mandated by recent legislation. This work will help all […]

Read More
  • As States Take the Lead to Address Drug Costs, Federal Action Follows
    State Health Policy Blog

    As states take the lead implementing dozens of innovative laws to curb the rising costs of prescription drugs, the federal government is following with a recent wave of proposed bills and rule changes designed to rein in drug costs nationally. This year, state legislatures approved an unprecedented number of measures to curb crippling drug costs, […]

    Read More
  • New NASHP Model Legislation Helps States Bring Transparency to Pharmacy Benefit Managers
    State Health Policy Blog

    The National Academy for State Health Policy (NASHP) has released model legislation to help states shed light on the opaque business practices of pharmacy benefit managers (PBMs). States can use the model bill to require the licensing of PBMs, ban gag clauses that prevent pharmacists from sharing lower-price drug options with consumers, and require more […]

    Read More
  • State Lawmaker Will Guzzardi Plots His Next Move to Curb Generic Drug Price Gouging in Illinois
    State Health Policy Blog

    Earlier this year, Illinois state Rep. Will Guzzardi proposed an aggressive, anti-price-gouging bill that banned manufacturers from excessively hiking the costs of generic drugs sold to Illinois residents for his first foray into prescription cost control legislation. Guzzardi’s bill was one of a dozen anti-price gouging measures introduced in state legislature this year. The bill […]

    Read More
  • Pharmacy Benefit Manager Model Legislation: Questions and Answers

    These questions and answers explain the role pharmacy benefit managers (PBM) play in the drug supply chain and highlight NASHP’s model PBM legislation that states can use to better oversee PBMs and protect consumers. What are pharmacy benefit managers? Pharmacy benefit managers (PBMs) contract with health plans to administer their pharmacy benefits. Depending what a health […]

    Read More
  • Twenty-Four States Passed 37 Bills to Curb Rising Rx Drug Costs in the Short 2018 Legislative Session
    State Health Policy Blog

    Despite a short legislative season, state lawmakers across the country introduced an unprecedented 160 bills to stem the rising cost of prescription drugs and have enacted 37 into law — with seven state legislatures still in session. Last year, state legislatures introduced 100 Rx cost control bills and passed 27. Register Now to Attend NASHP’s […]

    Read More
  • Feds Send Mixed Responses on States’ Efforts to Control Medicaid Drug Costs

    The Centers for Medicare & Medicaid Services (CMS) had a mixed response to two states’ innovative efforts to control Medicaid drug costs in June. The agency denied Massachusetts’ 1115 waiver request to create a closed Medicaid drug formulary, but it approved Oklahoma’s State Plan Amendment that authorizes supplemental rebates for value-based purchasing arrangements with pharmaceutical […]

    Read More
    July 10, 2018 | Filed under: All, Drug Pricing, Front Page, Front Page-Rx, Medicaid
  • A Glossary of All Terms Pharma

    If you’re working to control the cost of prescription drugs, you need to know the lingo used by the pharmaceutical industry. Below is a glossary of terms commonly used by players in the drug research, regulation, manufacturing, distribution, and purchasing worlds. Drug Product Terms Brand product: Branded products are not generic drugs or products. A brand can be […]

    Read More
  • Vermont First in the Nation to Approve Rx Drug Importation from Canada

    Vermont is the first state  in the nation to approve importation of less-costly prescription drugs from Canada. For the first time in the United States, obtaining low-cost prescription drugs from Canada is one step closer to reality today following the Vermont state legislature’s landmark enactment of S.175. Vermont Gov. Philip Scott signed the bill into law on […]

    Read More
  • While the Administration Mulls How to Curb Prescription Costs, State Legislatures Take the Lead
    State Health Policy Blog

    As the country awaits the Administration’s plan to curb Rx drug costs, states take the lead, proposing and passing legislation to lower costs, despite industry opposition. As we await the details of President Trump’s proposals to curb escalating drug prices, states are continuing to push legislation to lower the cost of prescription drugs, despite the strong […]

    Read More